These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Myeloid-derived suppressor cell role in tumor-related inflammation. Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992 [TBL] [Abstract][Full Text] [Related]
5. Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers. Roberson CD; Atay S; Gercel-Taylor C; Taylor DD Cancer Biomark; 2010-2011; 8(4-5):281-91. PubMed ID: 22045359 [TBL] [Abstract][Full Text] [Related]
6. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Filipazzi P; Bürdek M; Villa A; Rivoltini L; Huber V Semin Cancer Biol; 2012 Aug; 22(4):342-9. PubMed ID: 22369922 [TBL] [Abstract][Full Text] [Related]
7. Tumor escape mechanism governed by myeloid-derived suppressor cells. Nagaraj S; Gabrilovich DI Cancer Res; 2008 Apr; 68(8):2561-3. PubMed ID: 18413722 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs. Whiteside TL; Mandapathil M; Szczepanski M; Szajnik M Bull Cancer; 2011 Feb; 98(2):E25-31. PubMed ID: 21339097 [TBL] [Abstract][Full Text] [Related]
9. [The pattern recognition receptor-mediated immune tolerance is involved in tumor metastasis]. Hu ZW; Yang HZ Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):5-10. PubMed ID: 21417007 [TBL] [Abstract][Full Text] [Related]
10. Exosomes: from biogenesis and secretion to biological function. Keller S; Sanderson MP; Stoeck A; Altevogt P Immunol Lett; 2006 Nov; 107(2):102-8. PubMed ID: 17067686 [TBL] [Abstract][Full Text] [Related]
11. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216 [TBL] [Abstract][Full Text] [Related]
12. [Immune response and cancer]. El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571 [TBL] [Abstract][Full Text] [Related]
14. The Janus face of dendritic cells in cancer. Chaput N; Conforti R; Viaud S; Spatz A; Zitvogel L Oncogene; 2008 Oct; 27(45):5920-31. PubMed ID: 18836473 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of microvesicles derived from human colorectal cancer cells. Choi DS; Lee JM; Park GW; Lim HW; Bang JY; Kim YK; Kwon KH; Kwon HJ; Kim KP; Gho YS J Proteome Res; 2007 Dec; 6(12):4646-55. PubMed ID: 17956143 [TBL] [Abstract][Full Text] [Related]
16. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015 [TBL] [Abstract][Full Text] [Related]
17. Altered macrophage differentiation and immune dysfunction in tumor development. Sica A; Bronte V J Clin Invest; 2007 May; 117(5):1155-66. PubMed ID: 17476345 [TBL] [Abstract][Full Text] [Related]
18. Exosomes as intercellular signalosomes and pharmacological effectors. Record M; Subra C; Silvente-Poirot S; Poirot M Biochem Pharmacol; 2011 May; 81(10):1171-82. PubMed ID: 21371441 [TBL] [Abstract][Full Text] [Related]
19. The Uptake of Extracellular Vesicles is Affected by the Differentiation Status of Myeloid Cells. Czernek L; Chworos A; Duechler M Scand J Immunol; 2015 Dec; 82(6):506-14. PubMed ID: 26332303 [TBL] [Abstract][Full Text] [Related]